1,354
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: CLINICAL ONCOLOGY

Annual surgeon and hospital volume of gastrectomy and gastric adenocarcinoma survival in a population-based cohort study

, , , &
Pages 425-432 | Received 21 Oct 2021, Accepted 31 Dec 2021, Published online: 13 Jan 2022

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–249.
  • Ajani JA, Lee J, Sano T, et al. Gastric adenocarcinoma. Nat Rev Dis Primers. 2017;3:17036.
  • Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26–38.
  • Choi AH, Kim J, Chao J. Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond. World J Gastroenterol. 2015;21(24):7343–7348.
  • Katai H, Ishikawa T, Akazawa K, Registration Committee of the Japanese Gastric Cancer Association, et al. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007). Gastric Cancer. 2018;21(1):144–154.
  • Asplund J, Kauppila JH, Mattsson F, et al. Survival trends in gastric adenocarcinoma: a population-based study in Sweden. Ann Surg Oncol. 2018;25(9):2693–2702.
  • Maezawa Y, Aoyama T, Kano K, et al. Impact of the age-adjusted Charlson comorbidity index on the short- and long-term outcomes of patients undergoing curative gastrectomy for gastric cancer. J Cancer. 2019;10(22):5527–5535.
  • Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet (London, England). 2020;396(10251):635–648.
  • Van Cutsem E, Sagaert X, Topal B, et al. Gastric cancer. Lancet (London, England). 2016;388(10060):2654–2664.
  • Cancer AJCo. AJCC Cancer Staging Manual, Eighth Edition [Book]. 2016.
  • Derogar M, Sadr-Azodi O, Johar A, et al. Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study. J Clin Oncol. 2013;31(5):551–557.
  • Voeten DM, Busweiler LAD, van der Werf LR, Dutch Upper Gastrointestinal Cancer Audit (DUCA) Group, et al. Outcomes of esophagogastric cancer surgery during eight years of surgical auditing by the Dutch Upper Gastrointestinal Cancer Audit (DUCA). Ann Surg. 2021;274(5):866–873.
  • Iwatsuki M, Yamamoto H, Miyata H, et al. Effect of hospital and surgeon volume on postoperative outcomes after distal gastrectomy for gastric cancer based on data from 145,523 Japanese patients collected from a nationwide web-based data entry system. Gastric Cancer. 2019;22(1):190–201.
  • Iwatsuki M, Yamamoto H, Miyata H, et al. Association of surgeon and hospital volume with postoperative mortality after total gastrectomy for gastric cancer: data from 71,307 Japanese patients collected from a nationwide web-based data entry system. Gastric Cancer. 2021;24(2):526–534.
  • Ikoma N, Kim B, Elting LS, et al. Trends in volume–outcome relationship in gastrectomies in Texas. Ann Surg Oncol. 2019;26(9):2694–2702.
  • Wu JM, Ho TW, Tien YW. Correlation between the increased hospital volume and decreased overall perioperative mortality in one universal health care system. World J Surg. 2019;43(9):2194–2202.
  • Jensen LS, Nielsen H, Mortensen PB, et al. Enforcing centralization for gastric cancer in Denmark. Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2010;36(Suppl 1):S50–S54.
  • Anderson O, Ni Z, Møller H, et al. Hospital volume and survival in oesophagectomy and gastrectomy for cancer. Eur J Cancer (Oxford, England: 1990). 2011;47(16):2408–2414.
  • van Putten M, Nelen SD, Lemmens V, et al. Overall survival before and after centralization of gastric cancer surgery in The Netherlands. Br J Surg. 2018;105(13):1807–1815.
  • Asplund J, Gottlieb-Vedi E, Leijonmarck W, et al. Prognosis after surgery for gastric adenocarcinoma in the Swedish Gastric Cancer Surgery Study (SWEGASS). Acta Oncol (Stockholm, Sweden). 2021;60(4):513–518.
  • von Elm E, Altman DG, Egger M, STROBE Initiative, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–1499.
  • Roderick JA, Little DBR. Statistical analysis with missing data. 3rd ed. Chichester: West Sussex: John Wiley and Sons Ltd; 2019. (Wiley Series in Probability and Statistics).
  • Xirasagar S, Lien YC, Lin HC, et al. Procedure volume of gastric cancer resections versus 5-year survival. Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2008;34(1):23–29.
  • Kurokawa Y, Yamaguchi T, Sasako M, et al. Institutional variation in short- and long-term outcomes after surgery for gastric or esophagogastric junction adenocarcinoma: correlative study of two randomized phase III trials (JCOG9501 and JCOG9502). Gastric Cancer. 2017;20(3):508–516.
  • Mukai Y, Kurokawa Y, Takiguchi S, et al. Are treatment outcomes in gastric cancer associated with either hospital volume or surgeon volume? Ann Gastroenterol Surg. 2017;1(3):186–192.
  • Lagergren J, Smyth E, Cunningham D, et al. Oesophageal cancer. Lancet (London, England). 2017;390(10110):2383–2396.
  • Brusselaers N, Mattsson F, Lagergren J. Hospital and surgeon volume in relation to long-term survival after oesophagectomy: systematic review and meta-analysis. Gut. 2014;63(9):1393–1400.
  • Mackenzie H, Markar SR, Askari A, et al. National proficiency-gain curves for minimally invasive gastrointestinal cancer surgery. Br J Surg. 2016;103:88–96.
  • Markar SR, Ni M, Mackenzie H, et al. The effect of time between procedures upon the proficiency gain period for minimally invasive esophagectomy. Surg Endosc. 2020;34(6):2703–2708.